The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

Recruiting

Trial locations(8 sites)

United States

University of California, San Francisco, San Francisco, California

Massachusetts General Hospital, Boston, Massachusetts

Belgium

University Hospital Leuven, Leuven

Germany

University Hospital Heidelberg, Heidelberg

Technical University Munich, Munich

Netherlands

Erasmus MC, Rotterdam, South Holland

Medical Center Haaglanden, The Hague, South Holland

Switzerland

Inselspital Universitätsspital Bern, Bern